XML 14 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Balance Sheets (Unaudited) - USD ($)
Dec. 31, 2017
Jun. 30, 2017
Current assets:    
Cash and cash equivalents $ 34,958,048 $ 40,200,324
Available-for-sale investments 0 249,837
Accounts receivable 0 15,116,822
Prepaid expenses and other current assets 1,288,504 1,011,221
Total current assets 36,246,552 56,578,204
Property and equipment, net 178,767 198,153
Other assets 556,916 56,916
Total assets 36,982,235 56,833,273
Current liabilities:    
Accounts payable 703,767 1,551,367
Accrued expenses 5,527,776 10,521,098
Notes payable, net of discount and debt issuance costs 7,889,152 7,824,935
Capital lease obligations 0 14,324
Deferred revenue 9,548,228 35,050,572
Total current liabilities 23,668,923 54,962,296
Notes payable, net of discount and debt issuance costs 2,321,124 6,281,660
Deferred revenue 500,000 0
Other non-current liabilities 866,135 753,961
Total liabilities 27,356,182 61,997,917
Stockholders' equity (deficiency):    
Preferred stock of $0.01 par value - authorized 10,000,000 shares: Series A Convertible: issued and outstanding 4,030 shares as of December 31, 2017 and June 30, 2017 40 40
Common stock of $0.01 par value - authorized 300,000,000 shares: issued and outstanding 195,373,239 shares as of December 31, 2017 and 160,515,361 shares as of June 30, 2017, respectively 1,953,732 1,605,153
Additional paid-in capital 350,787,078 349,974,538
Accumulated other comprehensive loss 0 (590)
Accumulated deficit (343,114,797) (356,743,785)
Total stockholders' equity (deficiency) 9,626,053 (5,164,644)
Total liabilities and stockholders' equity (deficiency) $ 36,982,235 $ 56,833,273